PPT-Abbreviations: AF: atrial fibrillation, ACS: acute coronary syndrome, BD: twice daily,

CrCl creatinine clearance CTO chronic total occlusion DAPT dual antiplatelet therapy DOAC direct oral anticoagulant eDAN electronic discharge advice notification GFR glomerular filtration rate HF heart failure INR international normalised ratio LHP Leeds Health Pathways LTHT Leeds Teaching Hospitals NHS Trust LV left ventricular MACE major adverse cardiovascular event MI myocardial infarction NICE National Institute for Health and Care Excellence NSTEMI nonST segment elevation myocardial infarction STEMI ST segment elevation myocardial infarction OD once daily PAD peripheral arterial disease P2Y12 platelet receptor for adenosine diphosphate PCI percutaneous coronary intervention PPI proton pump inhibitor SPC summary of product characteristics TIA transient ischaemic attack. The LAA is a normal part of the heart anatomy and causes no problems in the general population However this pouch is a major source of blood clots in patients with atrial fibrillation Atrial fibrillation AF is the biggest risk factor for blood clots Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Journal Club . October 21,2015. Kathleen McNamara, . PharmD. Stroke Risk Calculation. Which tool do you most typically use to evaluate stroke . risk for patients with a fib? . CHADS2 score. CHADS2-VASc. Rhea C. Pimentel, MD. Associate Professor of Medicine. Fellowship Program Director, Clinical Cardiac Electrophysiology Program. Disclosures. Speakers Bureau: Medtronic. Speakers Bureau: St. Jude Medical. Martha Drake MS, FNP-BC. Chicago Heart and Vascular Consultants, LTD. Purdue Northwest Doctorate of Nursing Program. Learning Objectives. Discuss the incidence of atrial fibrillation (AF) in the population. A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. Cedar Mountain post acute rehabilitation center provide a therapeutic environment for our residents Yucaipa. Individualized treatment programs are developed with the interdisciplinary team of nursing, social services, Healthcare and dietary in consultation with your physicians. Dr. A- . Rai. Associated professor of Interventional cardiology. Kermanshah University of Medical science. Several features help to differentiate ACS from chronic stable angina, including (1) sudden onset . centre. , single-blind . randomised. controlled trial. Mario . Gaudino. , MD PhD MSCE FAHA. | . Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery , Weill Cornell Medicine. 2. Posterior left pericardiotomy for the prevention of postoperative atrial fibrillation after cardiac surgery: . Freedom . from atrial fibrillation at 12 . months: 63. % of the mitral valve surgery plus ablation group . vs. . 29% of the mitral valve surgery alone group (p < . 0.001). Among . the ablation group, freedom from atrial fibrillation occurred in 61% with PVI vs. 66% with . Prof. Dr. . Kurt Huber. , MD. Sigmund Freud University, Medical Faculty, and Wilhelminenspital . Vienna, Austria. 2. Please note: . The views expressed within this presentation are the personal opinions of the authors. . 2. Introduction. Chest Pain history. Physical Exam. Cardiac risk factors. Cardiac biomarkers. ECG in ACS. New . imaging modality. Treatments. Summary. Acute Coronary Syndrome. Acute coronary syndrome (ACS) .